<DOC>
	<DOC>NCT01198912</DOC>
	<brief_summary>This is a randomized, double blind, placebo controlled, parallel group, study in patients with chronic rhinosinusitis with or without nasal polyps. The objective is to test the clinical efficacy of long-term low dose oral doxycycline on wound healing quality after endoscopic sinus surgery.</brief_summary>
	<brief_title>Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>at least 18 years of age, of either sex and any race diagnosis of chronic rhinosinusitis with or without nasal polyposis according to the EPOS guidelines research Subjects should be regularly scheduled for bilateral functional endonasal endoscopic sinus surgery Subjects must be in good health, free of any clinically significant disease that would interfere with the study schedule or procedures or compromise his/her safety. Subjects must be willing to give informed consent and adhere to visit schedules, medication restrictions, and agree to perform daily diary entries. Nonpregnant women of childbearing potential must use a medically acceptable, adequate form of birth control. Women must not be pregnant, breast feeding, or premenarcheal. Subjects who have required oral corticosteroids within the previous four weeks prior to surgery. Subjects who have required nasal corticosteroids within the previous one week prior to surgery. Subjects with known allergic reaction on tetracyclines, diabetes (type 1 and 2), renal insufficiency, severe liver disease, systemic diseases affecting the nose (e.g. M. Wegener), prior surgeries of the paranasal sinuses. Patients with the following diseases should be excluded : 1. Cystic fibrosis based on positive sweat test or DNA alleles 2. Gross immunodeficiency (congenital or acquired) 3. congenital mucociliary problems e.g. primary ciliary dyskinesia (PCD) 4. Noninvasive fungal balls and invasive fungal disease 5. systemic vasculitis and granulomatous diseases 6. Cocaine abuse 7. Neoplasia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>rhinosinusitis</keyword>
	<keyword>doxycycline</keyword>
	<keyword>Chronic rhinosinusitis with or without nasal polyps</keyword>
</DOC>